Therefore, we first analysed whether obesity and its associated pathologies T2D and nonalcoholic fatty liver disease (NAFLD) influence the expression levels of DPT. In addition, the regulation of DPT by different inflammatory mediators was further explored in human visceral adipocytes. This evidence concerns the gene DPT and metabolic dysfunction-associated steatotic liver disease.